Eliza Dushku Pushes For Psychedelics Legalization In Massachusetts - A Personal Journey, A Public Cause

Zinger Key Points
  • Eliza Dushku joined healthcare professionals in Massachusetts to campaign for legalizing and regulating certain psychedelics.
  • Dushku's advocacy comes from her struggles with substance use and trauma, which she says psychedelic therapy greatly alleviated.
  • If passed, Ballot Question 4 would create a commission to oversee psychedelics and license therapy centers for adults over 21.

Eliza Dushku, known for roles in “Buffy the Vampire Slayer” and “Bring It On,” is turning her focus from Hollywood to health advocacy, leveraging her personal experience with psychedelic-assisted therapy to support Ballot Question 4 in Massachusetts. As Boston 25 News reported, Dushku joined healthcare professionals on Tuesday outside the State House to campaign for the legalization and regulation of certain psychedelics.

A Journey From Hollywood To Healing

Dushku's journey into advocacy stems from her struggles with substance use and childhood trauma, which she says were profoundly alleviated through psychedelic therapy. “It changed my life,” she told Boston 25 News. “I think I spent arguably most of my life numbing and taking drugs and alcohol to continue repressing the traumatic memories.” This deep shift, she believes, can help others facing mental health challenges.

Support From Research And Family

Along with her husband, Boston real state developer Peter Palandijan, Dushku envisions Massachusetts offering regulated psychedelic therapy. They cite promising research on psychedelics' benefits for veterans and individuals with mental health conditions like PTSD, anxiety, depression and addiction. “Psychedelics have the ability to drop you into the root cause of what your trauma is,” unlike many current treatments that target only symptoms,” says Dushku.

What Ballot Question 4 Proposes

If passed, Ballot Question 4 would create a state commission to oversee psychedelic use, licensing therapy centers where people 21 and older could access substances under professional supervision. Approved substances would include psilocybin, DMT, mescaline, ibogaine and psilocyn. The five-member commission would be appointed by the governor, attorney general and treasurer to set industry standards and regulations.

Concerns From Opponents

However, opponents argue that the proposed regulations may not address potential community impacts adequately. "If this were to pass the way this ballot question is written, all 351 cities and towns would have to allow these facilities into their communities," said Chris Keohan, spokesperson for the Coalition for Safe Communities. Opponents say they worry about risks associated with home cultivation and potential cost barriers to accessing legal products.

Massachusetts At A Crossroads

If the measure passes, Massachusetts would join Oregon and Colorado as states allowing specific psychedelics. Dushku and proponents of Ballot Question 4 say they hope that, with state oversight, psychedelic therapy can become a viable option for people struggling with profound mental health challenges.

Cover image: Tinseltown / Shutterstock

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsPsychedelicsRegulationsLegal2024 ballotcoalition for safe communitiesEliza DushkuMassachusetts legalizationPsychedelic Assisted Therapies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.